U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Patients with Type 2 diabetes and severe insulin resistance with very large insulin
requirements who have failed all previous insulin regimens using non-concentrated forms of
insulin (U100 insulin formulations) will receive 5X concentrated insulin (U500 regular
insulin)infused via insulin pump.